Bimekizumab Interactions
There are 225 drugs known to interact with bimekizumab, along with 4 disease interactions. Of the total drug interactions, 42 are major, 176 are moderate, and 7 are minor.
- View bimekizumab disease interactions (4)
Medications known to interact with bimekizumab
Note: Showing generic names only.
A
- abrocitinib
- adalimumab
- adenovirus vaccine
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- alprazolam
- aminophylline
- amiodarone
- amlodipine
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- apixaban
- atorvastatin
- avacopan
- azathioprine
B
C
- canakinumab
- candida albicans extract
- carbamazepine
- cat's claw
- certolizumab
- chikungunya vaccine, live (cvx 317)
- cholera vaccine
- cholera vaccine, live
- cladribine
- clobazam
- clonazepam
- coccidioidin skin test
- crizotinib
- cyclosporine
D
- dengue vaccine
- denosumab
- deucravacitinib
- diazepam
- dicumarol
- dimethyl fumarate
- diroximel fumarate
- disopyramide
- drospirenone
E
- echinacea
- efalizumab
- efgartigimod alfa
- etanercept
- ethinyl estradiol
- ethosuximide
- etonogestrel
- etrasimod
- everolimus
F
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
- hydrocodone
I
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- isradipine
J
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- levamlodipine
- levonorgestrel
- lidocaine
- lovastatin
- lurbinectedin
- lyme disease vaccine
M
- measles virus vaccine
- medroxyprogesterone
- melphalan
- melphalan flufenamide
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mephenytoin
- mephobarbital
- methadone
- mexiletine
- midazolam
- mirikizumab
- mixed respiratory vaccine
- monomethyl fumarate
- mumps skin test antigen
- mumps virus vaccine
N
- nadofaragene firadenovec
- natalizumab
- nicardipine
- nifedipine
- nimodipine
- nisoldipine
- norethindrone
- norgestrel
O
P
- pertussis, acellular
- phenobarbital
- phenytoin
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- ponesimod
- primidone
- procainamide
- propafenone
Q
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- rilonacept
- ritlecitinib
- rivaroxaban
- roflumilast
- rotavirus vaccine
- rozanolixizumab
- rsv vaccine pref3, recombinant
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
S
- saccharomyces boulardii lyo
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 5y-11y) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent vaccine
- sars-cov-2 (covid-19) mrna-1273 (6m-5y bivalent booster) vaccine
- sars-cov-2 (covid-19) mrna-1273 (bivalent booster) vaccine
- sars-cov-2 (covid-19) mrna-1273 bivalent vaccine
- sars-cov-2 (covid-19) mrna-1273 vaccine
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 311)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 312)
- sars-cov-2 (covid-19) mrna(tozinameran12y+) bivalent vaccine
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 (covid-19)mrna-1273(6y+ bivalent booster) vaccine
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- sars-cov-2(covid-19)mrna(tozinameran 5y-11y)bivalent vaccine
- simvastatin
- siponimod
- sipuleucel-T
- sirolimus
- skin test antigens, multiple
- smallpox and monkeypox vaccine
- smallpox vaccine
- staphage lysate (spl)
- sufentanil
T
- tacrolimus
- talimogene laherparepvec
- temsirolimus
- teriflunomide
- tetanus toxoid
- theophylline
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tofacitinib
- triazolam
- trichophyton skin test
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
- varicella virus vaccine
- venetoclax
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- vitamin e
- voclosporin
W
Y
Z
- zinc acetate
- zinc chloride
- zinc gluconate
- zinc sulfate
- zoster vaccine live
- zoster vaccine, recombinant
Bimekizumab disease interactions
There are 4 disease interactions with bimekizumab which include:
More about bimekizumab
- bimekizumab consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.